Outset Medical Inc.
OM | NASDAQ
$3.16
+$0.04 (+1.28%)
Sep 22, 2026, 9:55 AM ET · Market open
Company Profile
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Key Executives
| Name | Position |
|---|---|
| Leslie L. Trigg | President, Chief Executive Officer & Chairman |
| Renee Gaeta | Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer |
| Amelia Merrill | Vice President of People Operations & Culture |
| Brett Fogg | Senior Vice President of R&D & Operations |
| Brittni McGill | Chief Nursing Officer |
| Derick Elliott | Executive Vice President of Commercial |
| Dinamarie Stefani | Senior Vice President of Regulatory Affairs & Quality Assurance |
| Jaime Pulido | Senior Vice President of Finance |
| John L. Brottem | General Counsel & Secretary |
| Michael Aragon | Chief Medical Officer |
| Sara Mueller | VP of Marketing & Sales Effectiveness |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2026 | 8-K | Current Report |
| Aug 18, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 12, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 29, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 29, 2026 | 4 | Filing |
Outset Medical Inc.
| Country | United States |
| IPO Date | Sep 14, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 310 |
| CEO | Leslie L. Trigg |
Contact Details
3052 Orchard Drive San Jose,
California 95134 United States
Stock Details
| Ticker Symbol | OM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001484612 |
| CUSIP Number | 690145206 |
| ISIN Number | US6901452069 |
| SIC Code | 3845 |
Add to Watchlist
Select watchlists to add or remove OM